Leviten; Michael

Patent Applications and Registrations

Patent applications and USPTO patent grants for Leviten; Michael.The latest application filed is for "anti-complement factor c1q antibodies and uses thereof".

Company Profile

6.6.21

Leviten; Michael - Emerald Hills CA
Leviten; Michael - Palo Alto CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Anti-complement Factor C1q Antibodies And Uses Thereof App 20210277096 - Rosenthal; Arnon ; et al.	2021-09-09
Humanized Anti-complement Factor C1q Antibodies And Uses Thereof App 20210115119 - Rosenthal; Arnon ; et al.	2021-04-22
Anti-complement factor C1Q antibodies and uses thereof Grant 10,927,167 - Rosenthal , et al. February 23, 2	2021-02-23
Anti-complement Factor C1q Fab Fragments And Uses Thereof App 20200317765 - Yednock; Ted ; et al.	2020-10-08
Anti-complement Factor C1q Antibodies And Uses Thereof App 20200239557 - Rosenthal; Arnon ; et al.	2020-07-30
Anti-complement factor C1q Fab fragments and uses thereof Grant 10,723,788 - Yednock , et al.	2020-07-28
Anti-complement factor C1q antibodies and uses thereof Grant 10,590,190 - Rosenthal , et al.	2020-03-17
Humanized Anti-complement Factor C1q Antibodies And Uses Thereof App 20190315845 - Rosenthal; Arnon ; et al.	2019-10-17
Anti-complement Factor C1q Antibodies And Uses Thereof App 20190211084 - Rosenthal; Arnon ; et al.	2019-07-11
Humanized anti-complement factor C1Q antibodies Grant 10,316,081 - Rosenthal , et al.	2019-06-11
Anti-complement factor C1q antibodies and uses thereof Grant 10,227,398 - Rosenthal , et al.	2019-03-12
Compositions And Methods For Treatment Of Insulin-dependent Diabetes Mellitus App 20180092991 - Garren; Hideki ; et al.	2018-04-05
Anti-complement Factor C1q Antibodies And Uses Thereof App 20170334976 - Rosenthal; Arnon ; et al.	2017-11-23
Anti-complement factor C1q antibodies and uses thereof Grant 9,708,394 - Rosenthal , et al. July 18, 2	2017-07-18
Anti-complement Factor C1q Fab Fragments And Uses Thereof App 20170152309 - Yednock; Ted ; et al.	2017-06-01
Methods For Screening For Inhibitors Of Complement Serine Proteases App 20170081700 - Rosenthal; Arnon ; et al.	2017-03-23
Anti-complement Factor C1q Antibodies And Uses Thereof App 20160368973 - Rosenthal; Arnon ; et al.	2016-12-22
Humanized Anti-complement Factor C1q Antibodies And Uses Thereof App 20160355574 - Rosenthal; Arnon ; et al.	2016-12-08
Methods Of Treatment For Guillain-barre Syndrome App 20160326237 - Rosenthal; Arnon ; et al.	2016-11-10
Methods Of Treatment For Alzheimer's Disease And Huntington's Disease App 20160159890 - Rosenthal; Arnon ; et al.	2016-06-09
Anti-complement Factor C1s Antibodies And Uses Thereof App 20160090425 - Rosenthal; Arnon ; et al.	2016-03-31
Methods Of Treatment For Neuromyelitis Optica App 20160053023 - Rosenthal; Arnon ; et al.	2016-02-25
Compositions And Methods For Treatment Of Autoimmune Disease App 20100160415 - Solvason; Nanette ; et al.	2010-06-24
Methods And Immune Modulator Nucleic Acid Compositions For Preventing And Treating Disease App 20100130593 - Garren; Hideki ; et al.	2010-05-27
Polynucleotide Therapy App 20100048679 - Garren; Hideki ; et al.	2010-02-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.